DOI: 10.1055/s-00000175

Arzneimittelforschung

Issue 09 · Volume 62 · September 2012 DOI: 10.1055/s-002-23764

Review

  • 401
    Bittner, B.; Richter, W. F.; Hourcade-Potelleret, F.; McIntyre, C.; Herting, F.; Zepeda, M. L.; Schmidt, J.:

    Development of a Subcutaneous Formulation for Trastuzumab – Nonclinical and Clinical Bridging Approach to the Approved Intravenous Dosing Regimen

    • Original Article

  • 410
    Chang, M. J.; Shin, W. G.:

    Comparative Pharmacokinetics and Bioequivalence of Two 50 mg Atenolol Tablet Formulations in Healthy Korean Male Volunteers

  • 414
    Meno, H.; Inou, T.; Tanaka, M.; Tsuchiya, Y.; Shiga, Y.; Kobayashi, K.; Nakamura, Y.; Ota, T.; Kubara, I.:

    Efficacy and Effect on Plasma B-type Natriuretic Peptide Concentration of Losartan-hydrochlorothiazide for Hypertension Uncontrolled by Losartan-based Therapy: Subanalysis of a Multicentre Prospective Observational Study

  • 420
    Bansal, R.; Chauhan, P.; Sharma, R.:

    Synthesis and Anticonvulsant Activity of O-alkylated Derivatives of 1-(2-naphthyl)-2-(imidazol-1-yl)ethanone Oxime

  • 425
    Satheeshmanikandan, T.R. S.; Sridhar, V.; Kanthikiran, V.V. S.; Swaroopkumar, V.V. S.; Mukkanti, K.:

    Liquid Chromatography – Tandem Mass Spectrometry for the Simultaneous Quantitation of Glipizide, Cilostazol and its Active Metabolite 3, 4-dehydro-cilostazol in Rat Plasma: Application for a Pharmacokinetic Study

  • 433
    Alagarsamy, V.; Parthiban, P.:

    Design and Synthesis of Novel 3-(4-Chlorophenyl)-2-(3-Substituted Propyl Thio) Quinazolin-4-(3H)-ones as a New Class of H1-Antihistaminic Agents

  • 439
    Zhang, L.-X.; Zhang, S.-Q.; Cao, Y.-X.:

    Vasodilation and Hypotension of CZ454, an Analogue of Lacidipine through Inhibiting Extracellular Calcium Influx

    • Letter to the Editor

  • 446
    Locatelli, F.:

    Is Measuring Oxidative Stress, Inflammation and Tissue Damage Induced by Intravenous Iron in a Non-Clinical Model Relevant to Clinical Practice?